These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6112153

  • 1. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
    Davis A, Madras B, Seeman P.
    Eur J Pharmacol; 1981 Mar 26; 70(3):321-9. PubMed ID: 6112153
    [Abstract] [Full Text] [Related]

  • 2. Solubilization and characterization of striatal dopamine receptors.
    Lew JY, Goldstein M.
    J Neurochem; 1984 May 26; 42(5):1298-305. PubMed ID: 6707634
    [Abstract] [Full Text] [Related]

  • 3. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1985 May 26; 37(5):320-8. PubMed ID: 2862240
    [Abstract] [Full Text] [Related]

  • 4. Solubilization of D2 dopamine receptor coupled to guanine nucleotide regulatory protein from bovine striatum.
    Kuno T, Saijoh K, Tanaka C.
    J Neurochem; 1983 Sep 26; 41(3):841-7. PubMed ID: 6308173
    [Abstract] [Full Text] [Related]

  • 5. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X, Segawa T.
    Eur J Pharmacol; 1989 Aug 03; 166(3):401-10. PubMed ID: 2680521
    [Abstract] [Full Text] [Related]

  • 6. Solubilisation of high-affinity dopamine receptors.
    Gorissen H, Laduron P.
    Nature; 1979 May 03; 279(5708):72-4. PubMed ID: 450076
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of soluble dopamine D2-receptors from three species.
    Madras BK, Davis A, Seeman P.
    Eur J Pharmacol; 1982 Mar 26; 78(4):431-8. PubMed ID: 7075677
    [Abstract] [Full Text] [Related]

  • 8. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A, Seeman P.
    Biochem Pharmacol; 1987 Jul 01; 36(13):2095-9. PubMed ID: 2955789
    [Abstract] [Full Text] [Related]

  • 9. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF.
    Biochim Biophys Acta; 1989 Nov 27; 986(2):271-80. PubMed ID: 2531613
    [Abstract] [Full Text] [Related]

  • 10. Dopamine receptor of the porcine anterior pituitary gland. Solubilization and characterization.
    Kilpatrick BF, Caron MG.
    Biochem Pharmacol; 1984 Jun 15; 33(12):1981-8. PubMed ID: 6547344
    [Abstract] [Full Text] [Related]

  • 11. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M, Hidaka K, Nakamura Y.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):177-82. PubMed ID: 2576228
    [Abstract] [Full Text] [Related]

  • 12. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF, Memo M, Govoni S, Trabucchi M.
    Adv Biochem Psychopharmacol; 1980 Dec 07; 24():113-21. PubMed ID: 6105769
    [No Abstract] [Full Text] [Related]

  • 13. Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum.
    Murugaiah K, Theodorou A, Mann S, Clow A, Jenner P, Marsden CD.
    Nature; 1982 Apr 08; 296(5857):570-2. PubMed ID: 6122161
    [No Abstract] [Full Text] [Related]

  • 14. Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptors.
    Chan B, Seeman P, Davis A, Madras BK.
    Eur J Pharmacol; 1982 Jun 16; 81(1):111-6. PubMed ID: 6126367
    [Abstract] [Full Text] [Related]

  • 15. Drug potencies on partially purified brain D2 dopamine receptors.
    Madras BK, Seeman P.
    J Neurochem; 1985 Mar 16; 44(3):856-61. PubMed ID: 2579201
    [Abstract] [Full Text] [Related]

  • 16. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T, Seeman P.
    Adv Biochem Psychopharmacol; 1980 Mar 16; 21():435-42. PubMed ID: 6103653
    [Abstract] [Full Text] [Related]

  • 17. Solubilized receptors for [3H]dopamine (D3 binding sites) from canine brain.
    Davis A, Madras BK, Seeman P.
    Biochem Pharmacol; 1982 Apr 01; 31(7):1183-7. PubMed ID: 7092913
    [Abstract] [Full Text] [Related]

  • 18. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H, Sudo K, Sano M.
    Eur J Pharmacol; 1979 Nov 16; 59(3-4):245-51. PubMed ID: 43256
    [Abstract] [Full Text] [Related]

  • 19. Solubilization and characterization of 3H-spiroperidol binding sites of calf caudate.
    Lerner MH, Rosengarten H, Friedhoff AJ.
    Life Sci; 1981 Dec 07; 29(23):2367-74. PubMed ID: 6172690
    [No Abstract] [Full Text] [Related]

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov 07; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.